That does not mean GLP-1 medications are a problem
Researchers theorize this may be because: GIP activation may counterbalance some GLP-1 effects on the gut Dose escalation schedule allows more gradual adaptation Different pharmacokinetic profile may produce less pronounced peaks Serious Side Effects (Both Medications): These are rare but require immediate medical attention: Pancreatitis: Severe abdominal pain that may radiate to the back Risk: Less than 1% with both medications Usually occurs in first few months of treatment Requires immediate discontinuation if suspected Gallbladder Problems: Gallstones, cholecystitis (gallbladder inflammation) Symptoms: Right upper abdominal pain, nausea, fever More common with rapid weight loss May require surgical intervention Kidney Problems: Dehydration from vomiting/diarrhea can affect kidney function Watch for decreased urination, swelling in legs Stay well-hydrated, especially during side effect periods Thyroid Tumors (Black Box Warning): Both medications carry warnings about thyroid C-cell tumors Based on rodent studies
This causes the skin to develop pigmentation, tanning, signs of dullness or ageing, and uneven tone
Joint Swelling and Fluid Retention Research participants sometimes report mild joint fluid retention, particularly in knees, shoulders, and elbows
Furthermore, it may reduce inflammation, supporting studies on chronic gastrointestinal conditions
Gastroenterology 90:918923 Di Ciaula A, Portincasa P, Di Terlizzi L, Paternostro D, Palasciano G (2005) Ultrasonographic study of postcibal gastro-esophageal reflux and gastric emptying in infants with recurrent respiratory disease
